We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+10.98%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
-$4.56M
(-0.01%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
801
New
88
Increased
169
Reduced
396
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$165M |
| 2 |
Costco
COST
|
+$134M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$126M |
| 4 |
Johnson Controls International
JCI
|
+$121M |
| 5 |
3M
MMM
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$136M |
| 3 |
Marathon Petroleum
MPC
|
+$123M |
| 4 |
CenterPoint Energy
CNP
|
+$123M |
| 5 |
Under Armour
UAA
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.42% |
| 2 | Healthcare | 16.85% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VISN
101
Vistance Networks Inc
VISN
$2.67B
| $104M | 0.26% |
7,353,086
-913,895
| -11% | -$11.9M |
|
102
Louisiana-Pacific
LPX
$5.06B
| $103M | 0.25% |
3,468,123
+648,500
| +23% | +$18.3M |
|
103
CF Industries
CF
$19.3B
| $103M | 0.25% |
2,154,142
+1,888,000
| +709% | +$88.4M |
|
104
FirstEnergy
FE
$28B
| $102M | 0.25% |
2,104,592
+491,299
| +30% | +$23.5M |
|
105
Booking.com
BKNG
$150B
| $100M | 0.25% |
1,220,000
-72,500
| -6% | -$5.69M |
|
106
Huntington Ingalls Industries
HII
$12.9B
| $99.5M | 0.24% |
396,805
+20,934
| +6% | +$4.96M |
|
107
Amgen
AMGN
$208B
| $99M | 0.24% |
410,547
+38,300
| +10% | +$8.44M |
|
|
NVMI
108
Nova
NVMI
$12.6B
| $98.7M | 0.24% |
2,607,965
+192,933
| +8% | +$6.77M |
|
|
ATVI
109
DELISTED
Activision Blizzard
ATVI
| $98.6M | 0.24% |
1,659,225
+132,500
| +9% | +$7.33M |
|
|
XEC
110
DELISTED
CIMAREX ENERGY CO
XEC
| $97.9M | 0.24% |
1,864,555
-525,600
| -22% | -$24.4M |
|
111
Capital One
COF
$128B
| $97.2M | 0.24% |
944,482
-5,800
| -0.6% | -$559K |
|
112
S&P Global
SPGI
$122B
| $96.7M | 0.24% |
354,111
+56,500
| +19% | +$14.7M |
|
113
Ametek
AME
$55.7B
| $95.7M | 0.24% |
959,211
-56,101
| -6% | -$5.32M |
|
114
Intuitive Surgical
ISRG
$127B
| $95.6M | 0.23% |
485,205
-53,940
| -10% | -$10.1M |
|
115
Texas Instruments
TXN
$253B
| $95.1M | 0.23% |
741,144
-89,700
| -11% | -$11.1M |
|
116
Masco
MAS
$14.1B
| $93M | 0.23% |
1,937,700
-215,700
| -10% | -$9.81M |
|
117
Mondelez International
MDLZ
$79.7B
| $92M | 0.23% |
1,669,397
-79,900
| -5% | -$4.27M |
|
118
Evergy
EVRG
$19.2B
| $90.7M | 0.22% |
1,392,870
-742,600
| -35% | -$47.4M |
|
119
American Tower
AMT
$80.6B
| $90.4M | 0.22% |
393,366
-19,700
| -5% | -$4.29M |
|
120
Air Products & Chemicals
APD
$65.8B
| $89.5M | 0.22% |
380,984
+225,775
| +145% | +$51M |
|
121
Boston Scientific
BSX
$68.9B
| $89.3M | 0.22% |
1,975,311
+383,795
| +24% | +$16.1M |
|
122
Cigna
CI
$74.5B
| $89.3M | 0.22% |
436,698
-20,700
| -5% | -$3.8M |
|
123
Elevance Health
ELV
$81.8B
| $89.1M | 0.22% |
295,093
-16,500
| -5% | -$4.54M |
|
124
Gentex
GNTX
$4.99B
| $87.7M | 0.22% |
3,025,208
-727,762
| -19% | -$20.5M |
|
|
ALXN
125
DELISTED
Alexion Pharmaceuticals
ALXN
| $87.5M | 0.21% |
809,110
+242,148
| +43% | +$25.9M |
|
Similar funds
Adage Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Adage Capital Partners held 801 positions worth $40.7B, down 0.01% from $40.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Adage Capital Partners withdrew a net $3.46B in Q4 2019, closing 90 positions and reducing 396 holdings. Its most notable exit was Celgene Corp, an estimated $1.48B position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $142M.
- Adage Capital Partners's largest Q4 2019 buy was Bristol-Myers Squibb: 2,207,539 shares worth $142M.
- Adage Capital Partners added most to RTX Corp in Q4 2019, an estimated $165M increase.
- Adage Capital Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $136M.
- Adage Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.48B.
- Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q4 2019.
- Adage Capital Partners opened 88 new positions and closed 90 in Q4 2019.
- Adage Capital Partners's portfolio value fell 0.01% quarter-over-quarter to $40.7B.
Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.